抗病毒联合糖皮质激素和血浆置换早期干预肝衰竭倾向乙肝患者观察

山东大学学报(医学版) ›› 2012, Vol. 50 ›› Issue (3): 90-92.

抗病毒联合糖皮质激素和血浆置换早期干预肝衰竭倾向乙肝患者观察

谭林,李莎莎,高学武

阜阳市第二人民医院肝病科, 安徽阜阳 236015

收稿日期:2011-09-20 出版日期:2012-03-10 发布日期:2012-03-10
通讯作者: 李莎莎，女，主治医师，主要从事肝脏疾病的临床诊治研究。E-mail：fyeylss@163.com
作者简介:谭林(1966- )，男，主任医师，主要从事各种肝脏疾病的临床诊治研究。
基金资助:
安徽省卫生厅医学科研课题(09C175)

Effect of anti-virus combined with glucocorticoids and plasma exchange on
patients with hepatitis B with tendency to Hepatargia

TAN lin, LI Sha-sha, GAO Xue-wu

Department of Hepatology, Fuyang Second People′s Hospital, Fuyang 236015, Anhui, China

Received:2011-09-20 Online:2012-03-10 Published:2012-03-10

摘要/Abstract

摘要：

目的观察早期应用糖皮质激素和人工肝血浆置换在肝衰竭倾向患者治疗中的作用。方法选择91例有肝衰竭倾向的患者，其中治疗组49例，在综合保肝和抗乙肝病毒治疗基础上加用糖皮质激素或糖皮质激素联合人工肝血浆置换治疗；对照组42例，仅应用保肝联合抗病毒治疗。结果治疗过程中及治疗结束时，治疗组肝功能及凝血酶原的改善较对照组显著。治疗组临床好转率优于对照组，肝衰竭发生率低于对照组。结论应用糖皮质激素和人工肝血浆置换治疗，可早期阻断有肝衰竭倾向的慢性乙型肝炎疾病的进展，降低肝衰竭的发生率和慢性肝病的病死率，为肝衰竭的早期防治提供临床依据。

关键词: 肝衰竭倾向；早期干预；肝，人工；血浆置换；糖皮质激素

Abstract:

Objective To observe the effect of glucocorticoid and artificial liver plasma exchange in treatment of patients who had hepatargia tendency. Methods 91 patients with hepatargia tendency were assigned into the treatment group (n=49) and the control group (n=42). Based on the natural liver protection and anti-hepatitis B virus treatment, the treatment group received glucocorticoid or glucocorticoid in combination with artificial liver plasma exchange. The control group only received natural liver protection and anti-hepatitis B virus treatment. Results Compared with the control group, liver function and prothrombin in the treatment group was significantly improved during and after treatment. The clinical improvement rate was higher and the hepatargia incidence was lower. Conclusion Application of glucocorticoids and artificial liver plasma exchange, which can be blocked at an early stage of chronic hepatitis B tendency to hepatargia, reduces the incidence of liver failure and mortality of chronic liver disease, and provides a clinical basis for early prevention and treatment of hepatargia.

Key words: Hepatargia tendency; Intervention in early stage; Liver, artificial; Plasma exchange; Glucocorticoid

中图分类号:

R512.6

谭林,李莎莎,高学武. 抗病毒联合糖皮质激素和血浆置换早期干预肝衰竭倾向乙肝患者观察[J]. 山东大学学报(医学版), 2012, 50(3): 90-92.

TAN lin, LI Sha-sha, GAO Xue-wu. Effect of anti-virus combined with glucocorticoids and plasma exchange on
patients with hepatitis B with tendency to Hepatargia[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 90-92.

参考文献

相关文章 9

[1]	符晓莉，王磊，刘峰. 乙肝病毒感染不同阶段血清HBsAg定量值及其与HBV DNA水平和年龄的相关性[J]. 山东大学学报(医学版), 2013, 51(5): 94-98.
[2]	张秀珍,刘莉,刘倩. 慢性乙型肝炎患者血清瘦素水平与抗病毒治疗应答的相关性[J]. 山东大学学报(医学版), 2012, 50(9): 96-99.
[3]	孙超1，2, 解双双2, 肖迪2, 刘彩霞1,2, 于进红2, 刘莉2, 李强2. 急性乙型肝炎伴严重高胆红素血症的危险因素[J]. 山东大学学报(医学版), 2012, 50(8): 88-.
[4]	崔海彬1，崔速南2，汪明明2，张秀珍2，刘葵花2，郭楠1. 血浆渗透压评分对肝肾综合征的预后评价[J]. 山东大学学报(医学版), 2011, 49(6): 103-106.
[5]	关彦彦1，姚永远1，王刚1，邵丽华2，赛林涛1，马立宪1. DMSO、地塞米松对于HBV感染HepCHLine-4细胞能力的影响[J]. 山东大学学报(医学版), 2010, 48(10): 65-.
[6]	郭堑，农村立. 异甘草酸镁治疗伴高胆红素血症病毒性肝炎的疗效观察[J]. 山东大学学报(医学版), 2010, 48(8): 103-106.
[7]	李月荣1，2，韩增禄2，王磊1. 慢性乙型肝炎患者不同肝功能状况与胃黏膜病变的相关性[J]. 山东大学学报(医学版), 2010, 48(4): 94-97.
[8]	. 现有乙型肝炎多表位疫苗在中国人群中的理论免疫效果评价[J]. 山东大学学报(医学版), 2009, 47(10): 114-117.
[9]	. 基于GIS的中国人群乙肝多表位疫苗的预测[J]. 山东大学学报(医学版), 2009, 47(7): 125-132.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed